Patents by Inventor Lee W. Herman

Lee W. Herman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heteroaryl-isochroman compounds and uses thereof
    Patent number: 11491133
    Abstract: Compounds of Formula I are described as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric diseases and disorders in a subject in need are also disclosed.
    Type: Grant
    Filed: August 12, 2020
    Date of Patent: November 8, 2022
    Assignees: Sunovion Pharmaceuticals Inc., PGI Drug Discovery LLC
    Inventors: Carrie A. Bowen, Douglas F. Burdi, Michele L. R. Heffernan, Lee W. Herman, Linghong Xie
  • Dual NAV1.2/5HT2a inhibitors for treating CNS disorders
    Patent number: 11186564
    Abstract: Compounds of formula I: are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric disorders in a patient in need are also disclosed. Such disorders include depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, addiction, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, autism, a cognitive impairment, or a neuropsychiatric symptom such as apathy, depression, anxiety, psychosis, aggression, agitation, impulse control disorders, and sleep disorders in neurological disorders such as Alzheimer's and Parkinson's diseases.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: November 30, 2021
    Assignee: Sunovion Pharmaceuticals Inc.
    Inventors: Michele L. R. Heffernan, Larry Wendell Hardy, Scott P. Brown, Lee W. Herman
  • COMPOUNDS AND USES THEREOF
    Publication number: 20210093606
    Abstract: Compounds of Formula I are described as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric diseases and disorders in a subject in need are also disclosed.
    Type: Application
    Filed: August 12, 2020
    Publication date: April 1, 2021
    Applicants: Sunovion Pharmaceuticals Inc., PGI Drug Discovery LLC
    Inventors: Carrie A. Bowen, Douglas F. Burdi, Michele L. R. Heffernan, Lee W. Herman, Linghong Xie
  • Compounds and uses thereof
    Patent number: 10780074
    Abstract: Compounds of Formula I are described as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric diseases and disorders in a subject in need are also disclosed.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: September 22, 2020
    Assignees: Sunovion Pharmaceuticals Inc., PGI Drug Discovery LLC
    Inventors: Carrie A. Bowen, Douglas F. Burdi, Michele L. R. Heffernan, Lee W. Herman, Linghong Xie
  • DUAL NAV1.2/5HT2a INHIBITORS FOR TREATING CNS DISORDERS
    Publication number: 20190194163
    Abstract: Compounds of formula I: are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric disorders in a patient in need are also disclosed. Such disorders include depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, addiction, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, autism, a cognitive impairment, or a neuropsychiatric symptom such as apathy, depression, anxiety, psychosis, aggression, agitation, impulse control disorders, and sleep disorders in neurological disorders such as Alzheimer's and Parkinson's diseases.
    Type: Application
    Filed: August 4, 2016
    Publication date: June 27, 2019
    Applicant: Sunovion Pharmaceuticals Inc.
    Inventors: Michele L.R. HEFFERNAN, Larry Wendell HARDY, Scott P. BROWN, Lee W. HERMAN
  • COMPOUNDS AND USES THEREOF
    Publication number: 20190038594
    Abstract: Compounds of Formula I are described as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric diseases and disorders in a subject in need are also disclosed.
    Type: Application
    Filed: August 1, 2018
    Publication date: February 7, 2019
    Inventors: Carrie A. Bowen, Douglas F. Burdi, Michele L.R. Heffernan, Lee W. Herman, Linghong Xie